Adjunctive rifampicin to reduce early mortality from <it>Staphylococcus aureus</it> bacteraemia (ARREST): study protocol for a randomised controlled trial

Adjunctive rifampicin to reduce early mortality from <it>Staphylococcus aureus</it> bacteraemia (ARREST): study protocol for a randomised controlled trial

<p>Abstract</p> <p>Background</p> <p><it>Staphylococcus aureus</it> bacteraemia is a common and serious infection, with an associated mortality of ~25%. Once in the blood, <it>S. aureus</it> can disseminate to infect almost any organ, but bones,...

Full description

Bibliographic Details
Main Authors: Thwaites Guy, Auckland Cressida, Barlow Gavin, Cunningham Richard, Davies Gerry, Edgeworth Jonathan, Greig Julia, Hopkins Susan, Jeyaratnam Dakshika, Jenkins Neil, Llewelyn Martin, Meisner Sarah, Nsutebu Emmanuel, Planche Tim, Read Robert C, Scarborough Matthew, Soares Marta, Tilley Robert, Török M Estée, Williams John, Wilson Peter, Wyllie Sarah, Walker A Sarah
Format: Article
Language:English
Published: BMC 2012-12-01
Series:Trials
Subjects:
<it>Staphylococcus aureus</it>
Bacteraemia
Rifampicin
Mortality
Online Access:http://www.trialsjournal.com/content/13/1/241

Internet

http://www.trialsjournal.com/content/13/1/241

Similar Items